fluocinonide — CareFirst (Caremark)
corticosteroid-responsive dermatoses
Initial criteria
- Authorization may be granted when the requested drug is being prescribed for a corticosteroid-responsive dermatosis or condition (e.g., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) when the following criterion is met:
- • The requested drug is NOT being used in a footbath.
Approval duration
6 months